Insider Transactions Reported by 21 Insiders of Black Diamond Therapeutics, Inc.

Symbol
BDTX on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Black Diamond Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Versant Venture Capital VI, L.P. 10%+ Owner $28,747,309 28 Aug 2024
Ali Behbahani Director $17,945,203 12 Dec 2025
RA CAPITAL MANAGEMENT, L.P. Director $8,773,750 05 Jul 2023
BIOTECH GROWTH N V 10%+ Owner $5,786,646 -$11,997,749 -67% 19 Mar 2025
David M. Epstein Officer Title: President and Chief Executive Officer, Director $1,878,246 27 Jun 2023
Elizabeth Buck Chief Scientific Officer $425,480 21 Jan 2026
Mark A. Velleca PRESIDENT & CEO, Director $303,805 21 Jan 2026
Erika Jones Officer Title: Senior Vice President, Finance and Corporate Controller $212,875 21 Jan 2026
Brent Hatzis-Schoch Officer Title: Chief Operating Officer and General Counsel $208,500 21 Jan 2026
Sergey Yurasov Chief Medical Officer $187,500 21 Jan 2026
Wendy L. Dixon Director $172,765 15 Mar 2024
Robert Alexander Ingram Former Director $116,991 16 Dec 2022
Prakash Raman Director $85,634 12 Dec 2025
Shannon Campbell Director $22,163 12 Jun 2025
Bradley J. Bolzon PhD Director, 10%+ Owner 18 Jun 2021
Samarth Kulkarni Director 12 Jun 2025
Kapil Dhingra Director 12 Jun 2025
Fang Ni Officer Title: Chief Business Officer and Chief Financial Officer 14 Feb 2024
Alexander Mayweg Director 16 May 2023
Rajeev M. Shah Director 16 May 2023
Garry E. Menzel Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Black Diamond Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Erika Jones BDTX Stock Option (Right to Buy) Award 200,000 200,000 21 Jan 2026 Direct
Elizabeth Buck BDTX Stock Option (Right to Buy) Award 250,000 250,000 21 Jan 2026 Direct
Mark A. Velleca BDTX Stock Option (Right to Buy) Award 600,000 600,000 21 Jan 2026 Direct
Sergey Yurasov BDTX Stock Option (Right to Buy) Award 250,000 250,000 21 Jan 2026 Direct
Brent Hatzis-Schoch BDTX Stock Option (Right to Buy) Award 250,000 250,000 21 Jan 2026 Direct
Ali Behbahani BDTX Common Stock Award 6.39% 5,208 86,649 12 Dec 2025 Direct
Prakash Raman BDTX Common Stock Award 17.7% 4,665 31,027 12 Dec 2025 Direct
Ali Behbahani BDTX Common Stock Award 5.56% 4,291 81,441 19 Sep 2025 Direct
Prakash Raman BDTX Common Stock Award 17.1% 3,843 26,362 19 Sep 2025 Direct
Ali Behbahani BDTX Common Stock Award 8.69% 6,170 77,150 20 Jun 2025 Direct
Prakash Raman BDTX Common Stock Award 32.5% 5,526 22,519 20 Jun 2025 Direct
Ali Behbahani BDTX Stock Option (Right to Buy) Award 30,550 30,550 12 Jun 2025 Direct
Garry E. Menzel BDTX Stock Option (Right to Buy) Award 30,550 30,550 12 Jun 2025 Direct
Prakash Raman BDTX Stock Option (Right to Buy) Award 30,550 30,550 12 Jun 2025 Direct
Shannon Campbell BDTX Stock Option (Right to Buy) Award 30,550 30,550 12 Jun 2025 Direct
Kapil Dhingra BDTX Stock Option (Right to Buy) Award 30,550 30,550 12 Jun 2025 Direct
Samarth Kulkarni BDTX Stock Option (Right to Buy) Award 30,550 30,550 12 Jun 2025 Direct
Ali Behbahani BDTX Common Stock Award 12.1% 7,646 70,980 21 Mar 2025 Direct
Prakash Raman BDTX Common Stock Award 67.5% 6,848 16,993 21 Mar 2025 Direct
BIOTECH GROWTH N V BDTX Common Stock Sale -67.9% $11,997,749 $2.07 -5,784,292 2,733,547 19 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.